EFFICACY AND SAFETY OF OPEN-LABEL MAINTENANCE THERAPY WITH SUBCUTANEOUS RISANKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN’S DISEASE

Brian G. Feagan  1     Julian Panés  2     Marc Ferrante  3     Arthur Kaser  4     Geert R. D'Haens  5     William Sandborn  6     Edouard Louis     Markus Friedrich Neurath     Denis Franchimont     Olivier Dewit     Ursula Seidler     Kyung-Jo Kim     Christian Selinger     Steven J Padula     Ivona Herichova     Anne M. Robinson     Kori Wallace     Jun Zhao     Adina Soaita     Sudha Visva    
1 Robarts Clinical Trials,London,Canada
2 Hospital Clinic Barcelona,Barcelona,Spain
3 University Hospitals Leuven,Leuven,Belgium
4 University of Cambridge, Addenbrooke's Hospital,Cambridge,United Kingdom
5 Academic Medical Center, University of Amsterdam,Amsterdam,Netherlands
6 IBD Center University of California San Diego and UC San Diego H

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing